The impact of ABO blood group on the prevalence of transfusion-transmitted infections among blood donors in a tertiary-care hospital
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqae162 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Chilota Chibuife Efobi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Blood Transfusion, Nnamdi Azikiwe University, Nnewi Campus, Nnewi, Nigeria. Hauptthemen laut MEDLINE: Blood Donors, ABO Blood-Group System, Transfusion Reaction, Sexually Transmitted Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objectives
Transfusion-transmitted infections are a serious complication of blood transfusion. Devising a means of detecting at-risk blood donors may be beneficial in low- and middle-income countries such as Nigeria. We sought to determine the impact of ABO blood group on the prevalence of transfusion transmitted infections.
Methods
A retrospective observational study was carried out at the blood bank of Chukwuemeka Odumegwu Ojukwu University Teaching Hospital in Nigeria using data from blood donors. Information retrieved about donors included sex; blood group; and results of HIV, hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV), and Venereal Disease Research Laboratory screening results. Microsoft Excel was used to sort the data and, the data analysis was conducted using R, version 4.3.2 (R Foundation for Statistical Computing). P < .05 was considered statistically significant.
Results
A total of 2356 donor records were reviewed; the majority of these donors were male. The prevalence of HIV, HBsAg, HCV, and venereal diseases in the study population was 0.5%, 3.3%, 1.6%, and 0.6%, respectively. There was a possible increased risk of HCV among blood group B donors (P < .02799).
Conclusions
Blood group B donors were found to have a higher risk of contracting HCV infection than other donors. This finding could give more insights on donor selection and screening. Further studies that are more broadly based are required to validate our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Blood Transfusion, Nnamdi Azikiwe University, Nnewi Campus, Nnewi, Nigeria.
- Center for Cardiovascular Risk Research, East Tennessee State University, Johnson City, TN, US.
- Lagos State University College of Medicine, Lagos, Nigeria.
- Chukwuemeka Odumegwu Ojukwu University, College of Medical Sciences, Awka, Nigeria.
- Babcock University Teaching Hospital, Ilishan Remo, Ogun State, Nigeria.
- Department of Obstetrics and Gynecology, Mother of Christ Specialist Hospital, Enugu, Nigeria.
ORCID-Profile: Emeka Stanley Obi, Oluwatobi Faniyi, Onyinyechi Victoria Okam, Onyinyechukwu Joyce Ndubuisi, Jonathan Izuchukwu Obidiegwu, Favour Chinonso Emezue
Zitieren
APA
Efobi, C. C., Obi, E. S., Faniyi, O., Offiah, C. E., Okam, O. V., Ndubuisi, O. J., Obidiegwu, J. I., Chinonso Emezue, F., & Umeh, O. E. (2025). The impact of ABO blood group on the prevalence of transfusion-transmitted infections among blood donors in a tertiary-care hospital. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae162
Vancouver
Efobi CC, Obi ES, Faniyi O, Offiah CE, Okam OV, Ndubuisi OJ, et al. The impact of ABO blood group on the prevalence of transfusion-transmitted infections among blood donors in a tertiary-care hospital. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqae162
BibTeX
@article{Efobi2025,
author = {Efobi, Chilota Chibuife and Obi, Emeka Stanley and Faniyi, Oluwatobi and Offiah, Christian Elochukwu and Okam, Onyinyechi Victoria and Ndubuisi, Onyinyechukwu Joyce and Obidiegwu, Jonathan Izuchukwu and Chinonso Emezue, Favour and Umeh, Okechukwu Elijah},
title = {The impact of ABO blood group on the prevalence of transfusion-transmitted infections among blood donors in a tertiary-care hospital},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqae162}
}
EUVIMED